• Home/
  • Recurrent inversion polymorphisms in humans associate with genetic instability and genomic disorders

Recurrent inversion polymorphisms in humans associate with genetic instability and genomic disorders

Cell 2022
Porubsky D, et al

DavidPorubsky116WolframHöps216HufsahAshraf316PingHsunHsieh1BernardoRodriguez-Martin2FeyzaYilmaz4JanaEbler3PilleHallast4Flavia AngelaMaria Maggiolini56William T.Harvey1BarbaraHenning1Peter A.Audano4David S.Gordon17PeterEbert3PatrickHasenfeld2EvaBenito2QihuiZhu4Human Genome Structural Variation Consortium (HGSVC)…Jan O.Korbel.

Unlike copy number variants (CNVs), inversions remain an underexplored genetic variation class. By integrating multiple genomic technologies, we discover 729 inversions in 41 human genomes. Approximately 85% of inversions <2 kbp form by twin-priming during L1 retrotransposition; 80% of the larger inversions are balanced and affect twice as many nucleotides as CNVs. Balanced inversions show an excess of common variants, and 72% are flanked by segmental duplications (SDs) or retrotransposons. Since flanking repeats promote non-allelic homologous recombination, we developed complementary approaches to identify recurrent inversion formation. We describe 40 recurrent inversions encompassing 0.6% of the genome, showing inversion rates up to 2.7 × 10−4 per locus per generation. Recurrent inversions exhibit a sex-chromosomal bias and co-localize with genomic disorder critical regions. We propose that inversion recurrence results in an elevated number of heterozygous carriers and structural SD diversity, which increases mutability in the population and predisposes specific haplotypes to disease-causing CNVs.


This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.